Research programme: G protein-coupled receptor modulators - Eli Lilly/Suven Life Sciences

Drug Profile

Research programme: G protein-coupled receptor modulators - Eli Lilly/Suven Life Sciences

Latest Information Update: 10 Sep 2009

Price : $50

At a glance

  • Originator Eli Lilly; Suven Life Sciences
  • Class Small molecules
  • Mechanism of Action G protein-coupled receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Preclinical CNS disorders

Most Recent Events

  • 07 Sep 2009 A lead compound has been identified from this programme
  • 30 Mar 2009 Preclinical development is ongoing in India and the US
  • 29 Aug 2006 Preclinical trials in CNS disorders in India (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top